Literature DB >> 32157006

[Bone Marrow Metastases of Breast Cancer Treated with Endocrine Therapy-A Case Report].

Aoi Okamoto1, Akina Saito, Muneharu Konishi, Natsumi Shimada, Yoko Matsuo, Yuna Sugitani, Misao Soyama.   

Abstract

We report a case of bone marrowmetastases of breast cancer treated with endocrine therapy. A 54-year-old woman underwent right partial mastectomy and sentinel lymph node biopsy, followed by adjuvant chemotherapy and radiotherapy. She declined the endocrine therapy and was lost to follow-up after 3 postoperative years. After 9 postoperative years, she visited our hospital because of backache and an axillary lump. FDG-PET scan, incisional biopsy of the axillary lump, and bone marrowbiopsy revealed multiple bone and bone marrowmetastases of the breast cancer. She was treated with endocrine therapy(fulvestrant: FUL), which effectively decreased the FDG uptake in the metastatic lesions after 6 months. However, tumor markers elevated after 1 year and 6 months, and she is currently under combination therapy with aromatase inhibitors and CDK4/6 inhibitors.

Entities:  

Mesh:

Year:  2019        PMID: 32157006

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Bone Marrow Carcinomatosis in a Stage IV Breast Cancer Patient Treated by Letrozole as First-Line Endocrine Therapy.

Authors:  Tsuyoshi Nakagawa; Kumiko Hayashi; Ayumi Ogawa; Goshi Oda; Iichiro Onishi; Masahide Yamamoto; Mio Mori; Tomoyuki Fujioka; Toshiaki Ishikawa; Kentaro Okamoto; Hiroyuki Uetake
Journal:  Case Rep Oncol       Date:  2022-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.